KEGG   DRUG: Botulinum toxin type AHelp
Entry
D00783                      Drug                                   

Name
Botulinum toxin type A (JAN);
Botox (TN);
Dysport (TN)
Product
Source
Clostridium botulinum A [TAX:36826]
Class
Other
 DG02029  Muscle relaxant
  DG01696  Peripherally-acting muscle relaxant
 DG01696  Peripherally-acting muscle relaxant
Remark
Same as: C07946
Therapeutic category: 1229
ATC code: M03AX01
Chemical structure group: DG00772
Product (DG00772): D00783<JP/US> D02735<JP/US>
Efficacy
Skeletal muscle relaxant, Neuromuscular blocking agent
  Disease
Cervical dystonia [DS:H01608]
Target
SNAP25 [HSA:6616] [KO:K18211]
  Pathway
hsa04721  Synaptic vesicle cycle
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 M MUSCULO-SKELETAL SYSTEM
  M03 MUSCLE RELAXANTS
   M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
    M03AX Other muscle relaxants, peripherally acting agents
     M03AX01 Botulinum toxin
      D00783  Botulinum toxin type A (JAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  12  Agents affecting peripheral nervous system
   122  Skeletal muscle relaxants
    1229  Others
     D00783  Botulinum toxin type A (JAN)
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Nervous system
   Synaptic vesicle
    SNAP25
     D00783  Botulinum toxin type A (JAN) <JP/US>
BRITE hierarchy
Other DBs
CAS: 93384-43-1
PubChem: 7847848
ChEBI: 3160
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system